Other Specified Bipolar and Related Disorder: What the Diagnosis Means
Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy
Other specified bipolar and related disorder is a recognized diagnostic category in the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). It is used when a person has clinically significant symptoms characteristic of a bipolar-related condition, yet the presentation does not fulfill every requirement for bipolar I disorder, bipolar II disorder, cyclothymic disorder, or another more specific condition in that class. Crucially, the clinician identifies the particular reason that the established criteria are unmet. American Psychiatric Association DSM-5-TR explanation
The diagnosis can describe recognizable patterns of short-duration hypomanic symptoms, hypomanic symptoms below the required count, a hypomanic episode without a previous major depressive episode, or a shorter-than-required cyclothymic presentation. The DSM-5-TR also includes a specialized example involving a manic episode superimposed on a separate psychotic disorder. These presentations require careful clinical interpretation. They are not interchangeable, and their implications for treatment and future course can differ. Oliva and colleagues' clinical review
For someone reading this diagnosis in a medical record, the central questions are what clinical pattern was documented, which exact criterion was unmet, what alternative explanations were evaluated, and what follow-up is planned. A diagnosis provides a working clinical description and a basis for care; it is not a prediction that the person will inevitably develop bipolar I or bipolar II disorder. NIMH diagnostic overview
For additional clinical context, see Types of Bipolar Disorder: Bipolar I, Bipolar II, Cyclothymia, and Other Forms and Bipolar Spectrum: Meaning, Clinical Uses, and Diagnostic Limits.
What does “other specified” mean in a bipolar diagnosis?
The words “other specified” have a technical purpose in DSM classification. They tell another clinician that the examining professional recognized a bipolar-related clinical presentation and can explain exactly why it falls outside the full criteria for the established bipolar categories. This is different from simply saying that mood symptoms are unusual or that a diagnosis remains unknown. The specific explanation should be recorded with the category. American Psychiatric Association DSM-5-TR note
The category addresses a real clinical problem: some people have distinct, recurring changes in mood, energy, sleep, and behavior that are significant enough to deserve evaluation but fall just short of a particular episode-duration or symptom-count rule. Diagnostic thresholds make communication and research more consistent, while clinical judgment still needs to account for distress, impairment, longitudinal pattern, and alternative causes. Miller, Dennehy, and Suppes on the four-day hypomania threshold
Clinical significance is established through the history and consequences of the symptoms, not merely by being close to a DSM cutoff. A two-day period of highly increased activity could reflect a bipolar-related syndrome, a stimulant effect, acute sleep loss, an understandable response to events, or another condition. The pattern across time, observed change from baseline, context, associated symptoms, and relevant exclusions determine what the clinician concludes. NICE assessment recommendations
How the diagnosis differs from bipolar I, bipolar II, and cyclothymia
Bipolar I disorder
Bipolar I requires at least one manic episode meeting the clinical criteria. A typical duration threshold is at least seven days, unless hospitalization is necessary, and mania involves substantial severity or impairment; psychotic features make the episode manic rather than hypomanic. Major depressive episodes frequently occur but are not required for bipolar I. The diagnostic framework and its severity requirements are described in the NIMH overview and the 2025 Lancet review.
Bipolar II disorder
Bipolar II requires at least one hypomanic episode and at least one major depressive episode, with no history of mania. A full hypomanic episode usually lasts at least four consecutive days, includes a characteristic change in mood and energy or activity, is observable as a change from the person’s usual behavior, and does not reach the severity of mania. Bipolar II can involve severe depression and major functional burden; it should not be called a mild version of bipolar I. See the Bipolar II clinical guide and NIMH.
Cyclothymic disorder
Cyclothymia describes a long-lasting pattern of fluctuating hypomanic and depressive symptoms that do not meet the full episode criteria; in adults the required duration is generally at least two years, with additional pattern requirements. When a comparable pattern has not persisted long enough, the DSM other-specified category may become relevant. This distinction relies on the complete history rather than one mood diary entry. The cyclothymic disorder guide explains the longitudinal picture. Singh and colleagues, 2025
Other specified and unspecified presentations
In other specified bipolar and related disorder, the reason the full criteria are not met is explicitly given. Unspecified bipolar and related disorder is used when characteristic symptoms are present but the clinician does not specify the reason, sometimes because information is incomplete or the circumstances do not allow detailed assessment. Either label can warrant continuing clinical care. The distinction is about what is known and documented, not an automatic severity ranking. Oliva and colleagues
The main DSM-5-TR examples
1. Short-duration hypomanic-like episodes (2–3 days) and major depressive episodes
One recognized example involves a history of major depressive episodes together with distinct hypomanic-like periods lasting only two or three days. These periods can contain the characteristic symptoms of hypomania, but do not reach the standard four-day minimum. The short elevated periods must be carefully distinguished from symptoms occurring within a depressive episode and from sleep deprivation, medication effects, or substance-related changes. This presentation should not be diagnosed simply because someone has one energetic weekend. Miller and colleagues' diagnostic-validity review
The four-day boundary is a diagnostic convention developed for reliability, and researchers have debated how well it captures real clinical patterns. Studies suggest some people with shorter high-energy episodes and major depression share clinical characteristics with bipolar-spectrum populations. That finding supports serious assessment; it does not establish that all brief changes are hypomania or that every such presentation should receive the same medication. Miller, Dennehy, and Suppes, 2016
2. Hypomanic-like episodes with insufficient symptoms and major depressive episodes
Another example includes a person with major depressive episodes and recurrent or distinct periods of elevated or irritable mood and increased energy/activity lasting long enough to resemble hypomania, but with too few accompanying symptoms to satisfy the full hypomanic episode criteria. A clinician examines sleep need, speech, racing thoughts, distractibility, goal-directed behavior, impulsive decisions, observable change from baseline, and effects on functioning, including whether the pattern truly occurs as an episode. Clinical review of bipolar diagnostic categories
The phrase “insufficient symptoms” describes a specific unmet symptom-count requirement. It does not mean the person is exaggerating, or that a treatment decision can be made by counting symptoms without regard to clinical context. The record should identify which clinical observations supported the bipolar-related formulation and which alternatives remain possible. NICE structured assessment guidance
3. A hypomanic episode without a previous major depressive episode
A person can experience a genuine hypomanic episode without a history of a major depressive episode. That history does not satisfy bipolar II, which requires both. The DSM-5-TR retains this presentation as an example of other specified bipolar and related disorder, provided other causes and diagnostic exclusions have been considered. The American Psychiatric Association specifically revised the explanatory wording in DSM-5-TR to clarify its relationship with persistent depressive disorder criteria. APA DSM-5-TR change note
Someone may seek help because friends observed marked behavioral change, a clinician noticed a history of reduced need for sleep and increased activity, or risky decisions created consequences even without prior depression. Follow-up matters because future information can clarify the pattern. The current diagnosis should reflect present evidence, not a forecast of which episode must occur next. NIMH on lifetime diagnostic history
4. Short-duration cyclothymic-like disorder (less than 24 months)
The other-specified category can also apply to a cyclothymic-like pattern that has not persisted for the required two years in an adult. The repeated oscillation and overall symptom pattern matter more than isolated bad days or ordinary personality variation. Clinicians assess whether the symptoms are characteristic of the bipolar-related class, whether they cause clinically significant difficulties, and whether medical, substance-related, or other mental-health explanations better fit. Singh and colleagues' diagnostic review
5. A manic episode superimposed on a psychotic disorder
The DSM-5-TR explicitly added a fifth example: a manic episode occurring alongside a preexisting psychotic disorder whose own diagnostic criteria do not include mood episodes and cannot account for the mania. The American Psychiatric Association describes why this situation is coded separately rather than automatically classifying the person as having bipolar I. It requires careful psychiatric assessment of the psychotic disorder, timing and independence of symptoms, and manic episode criteria. APA official DSM-5-TR explanation
This complex example is especially important because the presence of psychosis changes the clinical risk assessment and differential diagnosis. A manic syndrome with psychotic symptoms cannot be treated as routine hypomania. Clinicians distinguish psychotic symptoms confined to mood episodes from psychotic symptoms occurring independently, while also considering substance-induced and medical causes. NICE differential assessment
What symptoms might lead a clinician to consider the diagnosis?
The most informative clinical feature is a clear episodic change from usual functioning, especially in energy and activity together with mood. Possible elevated-phase symptoms include unusually elevated or expansive mood, substantial irritability, markedly increased talkativeness, faster thoughts, reduced need for sleep without feeling tired, amplified confidence, distractibility, many new projects, and risk-taking. The exact combination, duration, context, and consequences are essential. NIMH symptom overview
Depressive phases, when present, can involve loss of pleasure, low mood, fatigue, disturbed appetite or sleep, psychomotor changes, difficulty concentrating, hopelessness, guilt, and thoughts of death. A major depressive episode has its own symptom and duration criteria. The presence of depression alone does not establish a bipolar-related diagnosis. A careful history of elevated or activated periods must accompany evaluation of depression. NIMH
A reduced need for sleep differs from insomnia. With reduced sleep need, someone may sleep much less yet feel unusually energetic; with insomnia, a person usually wants more sleep but cannot obtain it and often feels tired. Increased activity during deadline pressure, travel, early parenthood, or irregular shift work also has to be interpreted alongside the broader clinical picture. The distinction helps avoid converting everyday circumstances into psychiatric episodes. NICE history and trigger assessment
The diagnosis may also be considered when several episodes recur but standard duration or symptom thresholds remain unmet. Recurrence adds clinical information, though recurrence alone is not diagnostic. The clinician should examine the quality of each episode, whether it is observable, the person's usual temperament, symptom-free intervals, and whether other disorders account for the pattern. VA/DoD bipolar assessment guideline
How clinicians assess other specified bipolar and related disorder
A longitudinal interview
Assessment begins by reconstructing the course of mood and energy changes over months or years. Clinicians ask what changed from the person’s baseline, when episodes began and ended, how many days symptoms lasted, whether symptoms were present through most of each day, what changed in behavior, and what happened afterward. They explore major depression, prior mania, hospitalization, episodes with psychosis, treatment responses, and the effect on work, school, relationships, finances, and safety. NICE recommendation 1.3.2
Because high-energy states may feel productive rather than troubling, the person might remember depression more readily. With consent, observations from a partner, relative, close friend, or previous care records can improve the time line. The objective is to understand the actual episodes, not to let another person decide the diagnosis. For a fuller discussion, see How Is Bipolar Disorder Diagnosed? and the NIMH diagnosis section.
Assessing the reason full criteria are not met
A careful record answers a precise question: Is the missing requirement episode duration, number of symptoms, absence of a required prior depressive episode, total duration of a cyclothymic-like course, or an episode that must be described alongside another psychiatric diagnosis? In DSM terminology, that reason differentiates an other-specified diagnosis from an unspecified one. The diagnostic explanation should survive clinical handoffs and future reassessment. APA DSM-5-TR documentation
Screening questionnaires and their limits
Tools such as the Mood Disorder Questionnaire (MDQ) and Hypomania Checklist-32 (HCL-32) may help organize symptoms in some clinical settings, but they cannot establish other specified bipolar and related disorder. Accuracy depends on the setting, patient population, and chosen threshold. A short-duration episode can be missed by a measure calibrated for full criteria, while a positive response can reflect ADHD, substance effects, anxiety, or another presentation. VA/DoD guideline
NICE explicitly advises against using questionnaires in adult primary care to identify bipolar disorder as a stand-alone approach. Interview-based assessment, clinical history, and differential diagnosis remain essential. The Hub's bipolar screening tests guide explains why a positive or negative score should not be read as a diagnosis. NICE recommendation 1.2.3
Physical health, medications, and substance review
Depending on symptoms and context, an assessment may include a physical examination and tests to evaluate medical explanations. Thyroid dysfunction, neurological conditions, medications, stimulants, other substances, and sleep disruption may resemble or aggravate mood activation. The clinician also reviews prescribed medications and any temporal relationship between starting a substance and a change in behavior. NIMH differential diagnosis
Family history of bipolar disorders and previous psychiatric admissions can inform clinical judgment but do not prove the individual has a particular bipolar diagnosis. The assessment also considers comorbid anxiety, ADHD, substance use, trauma-related symptoms, and psychotic disorders. The relevant history can change with time, which is why diagnostic review may be appropriate after a new well-characterized episode. NICE assessment guidance
Differential diagnosis: what else can look similar?
Major depressive disorder and depression with mixed features
People frequently present for depressed mood before any high-energy pattern is recognized. Clinicians determine whether there have been separate hypomanic-like periods, what their duration and symptom profile were, and whether activated symptoms arose only within depression. Major depressive disorder, a depressive episode with mixed features, and other specified bipolar-related presentations can require different formulations. A history of depression by itself is insufficient to choose between them. Oliva and colleagues
ADHD, persistent emotional reactivity, and personality-related difficulties
Attention difficulties, impulsivity, variable emotional reactions, and changing activity levels can appear in ADHD and other conditions. ADHD symptoms typically have a persistent developmental pattern, while bipolar-related diagnoses depend heavily on distinct departures from a person's baseline that occur in episodes. Clinicians assess both possibilities where warranted; co-occurrence is also possible. NICE differential diagnoses
Rapid shifts in mood in response to interpersonal events may have a different time course and context from sustained episodes of altered energy and sleep need. Borderline personality disorder and bipolar-related conditions are evaluated through their respective longitudinal criteria, developmental history, and associated features. An isolated conflict, a strong emotional response, or a period of irritability does not establish either diagnosis. NICE assessment recommendations
Psychotic disorders and substance- or medication-induced syndromes
Schizophrenia spectrum disorders and mood disorders with psychotic features require evaluation of the relationship between mood episodes and psychotic symptoms. Stimulants, corticosteroids, certain other medications, and substance use can contribute to activation or apparent mania. A comprehensive timeline is essential because the correct diagnosis may be a substance-induced or medical-condition-related disorder rather than other specified bipolar and related disorder. NIMH
Usual mood variability
Ordinary changes in mood, energy, or motivation are common and generally respond to sleep, stress, environment, and experiences. A clinical bipolar-related presentation requires a meaningful syndrome with sustained, characteristic changes and clinically significant consequences after careful evaluation. Someone who feels enthusiastic one day and discouraged the next should not infer a bipolar-related condition from that contrast. NIMH clinical overview
Causes and mechanisms: what science actually establishes
Bipolar disorders have complex, multifactorial associations involving inherited vulnerability, biological regulation, environmental exposures, stress, and circadian processes. Studies of established bipolar I and II disorders support this broader picture. The evidence does not permit a clinician to assign a unique gene, brain scan pattern, or neurotransmitter imbalance as the cause of one person's other-specified presentation. 2025 Lancet review
Research into shorter-duration hypomania suggests the usual categorical thresholds may not map perfectly onto clinically meaningful variation. Yet populations defined by brief or subthreshold symptoms are heterogeneous, and different studies apply different operational criteria. It is more accurate to view this literature as evidence of clinically relevant patterns than as proof of one unified underlying biological condition. Miller and colleagues' review
Sleep and wake rhythms, psychosocial stress, changes in routine, medications, and substance exposure can interact with vulnerability, but their presence is not itself diagnostic. A person may have several vulnerabilities without developing clinically significant episodes. Research supports asking about these factors when planning care; it does not justify assigning a cause from a single stressful event. Oliva and colleagues
How common is it, and what does the evidence tell us about prognosis?
Prevalence estimates for bipolar-spectrum and subthreshold syndromes depend strongly on definitions, interview instruments, and sampled populations. A large World Mental Health survey analysis showed that spectrum presentations contribute to the overall burden of bipolar-related conditions, but its research-defined subthreshold group cannot be treated as a current DSM-5-TR prevalence estimate for other specified bipolar and related disorder. Merikangas and colleagues, 2011
Some people who initially display subthreshold bipolar presentations later meet full criteria for bipolar I or bipolar II; others remain below those thresholds or receive a different diagnosis after longitudinal assessment. For example, an older prospective study of referred youth meeting operationalized bipolar disorder not otherwise specified criteria found substantial diagnostic progression over follow-up. Those data come from a selected pediatric cohort under an earlier diagnostic construct and cannot be used as a personal risk calculator for all adults given today's other-specified diagnosis. Axelson and colleagues, 2011
There is no scientifically defensible rule that other specified bipolar and related disorder is merely the first stage of bipolar I or II. A clinician can consider family history, recurrent episodes, symptom severity, prior course, treatment responses, and changes over time without claiming a certain trajectory. Planned reassessment can help refine diagnosis if new evidence emerges. Miller and colleagues
This is also why symptom improvement and clinical stability are meaningful even if the diagnostic label evolves. Care aims to reduce distress, protect safety, improve functioning, and identify changes early. A diagnostic revision may represent better information, an evolving condition, or reconsideration of alternative causes; it does not automatically establish that earlier care was inadequate. VA/DoD clinical guideline
Treatment: how clinicians decide what is appropriate
Treatment is individualized around current symptoms, severity, functional impairment, prior episodes, diagnostic confidence, risks, preferences, medical conditions, and whether immediate safety concerns exist. Most major treatment trials and formal guideline recommendations focus on bipolar I or bipolar II and on specific phases such as acute mania, bipolar depression, and maintenance. There is considerably less direct randomized evidence for each DSM-5-TR other-specified presentation. Clinicians must recognize that evidence gap before extrapolating. CANMAT/ISBD update
Psychological interventions and shared care planning
Psychoeducation, structured mood and sleep monitoring, identifying personal early warning signs, problem-solving around medication adherence when relevant, and family or individual psychotherapy can form part of a care plan. These approaches have supportive evidence in established bipolar disorders, including relapse prevention, but they should be adapted to the individual's actual needs rather than presumed to have identical effects in every subthreshold subtype. NICE psychological care recommendations
An effective collaborative plan specifies current problems, goals, clinician follow-up, signs requiring earlier contact, and what to do during worsening depression or marked activation. It can include financial safeguards during impulsive periods, regular sleep opportunities, substance-use discussion, and permission to involve trusted supporters where appropriate. Personal choice, cultural context, and practical access to care influence which approaches can be sustained. VA/DoD recovery-oriented care
Medication decisions
Medication may be considered when there is meaningful bipolar-related symptom burden, but an other-specified label alone does not mandate a particular drug. The evidence for treating acute mania differs from that for bipolar depression and from maintenance prevention. Clinicians may weigh available evidence from more clearly defined populations alongside the patient's episode history, current severity, risks, tolerability, and preferences. This is especially important when the observed periods are short or diagnostically uncertain. CANMAT/ISBD 2023 evidence update
Lithium can be highly effective for selected people with established bipolar disorders but requires baseline evaluation, kidney and thyroid monitoring, serum level measurements, review of interacting drugs, and awareness of toxicity risk during dehydration or acute illness. The decision to use it for an other-specified presentation requires a clear clinical rationale and supervised monitoring. Patients should not start, stop, or modify lithium without a prescribing professional. NICE lithium monitoring guidance
Lamotrigine has evidence in selected bipolar-depressive and maintenance contexts, but it is not an acute antimanic treatment. Its introduction requires careful titration and urgent clinical evaluation of potentially serious new rashes. Valproate has important reproductive and developmental risks and is subject to stringent safeguards in some jurisdictions; its use requires specialized consideration of pregnancy potential, liver and blood-related risks, interactions, and monitoring. Neither medicine should be inferred as appropriate from this diagnostic label alone. NICE medication guidance
Second-generation antipsychotics are sometimes used for specific bipolar phases, with the chosen medicine depending on efficacy, adverse-effect profile, and indication. Potential harms include metabolic changes, weight gain, sedation, movement disorders, and drug-specific cardiovascular considerations. When prescribed, clinicians monitor physical health and response. The existence of milder or shorter symptoms does not make these medications automatically suitable or risk-free. NICE antipsychotic monitoring recommendations
Antidepressant prescribing requires attention to any history of activation, mania, hypomania, mixed features, or worsening cycling. Guidelines for established bipolar I depression caution against antidepressant monotherapy because of the risk of treatment-emergent mood switching, while the magnitude and applicability of that risk vary by drug, population, and setting. Decisions in diagnostically uncertain presentations require evaluation by a qualified prescriber; people already taking medication should discuss concerns before changes. CANMAT/ISBD update
Treating depression, activation, and maintenance as separate questions
A person who is acutely depressed needs assessment of the depressive syndrome and its risks. Someone becoming severely activated, sleeping very little with increasing agitation, or losing judgment may require a different and more urgent response. Long-term relapse prevention is a third clinical problem. Evidence for a medicine during one phase should not be treated as proof of benefit in another phase; treatment review must stay matched to the actual condition and phase. 2023 VA/DoD treatment modules
When urgent assessment is important
Urgent mental-health evaluation is appropriate when elevated or irritable mood is accompanied by rapidly worsening judgment, extreme agitation, substantial sleep reduction, dangerous behavior, suspected mania, or psychosis; likewise when depression becomes severe or suicidal thoughts arise. NICE specifically recommends urgent specialist assessment for suspected mania, severe depression, or danger to self or others. NICE clinical recommendations
If someone has immediate intent to harm themselves or another person, cannot stay safe, experiences severe confusion, or has escalating psychosis or mania that threatens safety, contact local emergency services or go to an emergency department. In the United States, calling or texting 988 can connect a person with crisis support; local emergency services remain the appropriate route for immediate medical danger. Family members should focus on safety and professional evaluation rather than trying to argue someone out of an episode. NIMH clinical overview
A person with a written crisis or relapse plan can share it with the treating team and trusted supporters. Warning signs, preferred contacts, medication information, and practical steps regarding driving, money, and sleep should be individualized. This is particularly relevant when the person's episode pattern is still being clarified; uncertainty about the final diagnosis should never delay response to an immediate safety issue. NICE risk assessment and crisis planning
Special considerations across the lifespan
Children and adolescents
Diagnosis in young people requires developmentally informed assessment. Normal developmental variability, ADHD, trauma, disruptive behavior, sleep problems, and medication effects can create diagnostic overlap. Research in pediatric subthreshold bipolar syndromes shows that prospective course can matter, but samples and definitions vary. Findings from referred youth should not be directly transferred to an adult newly given an other-specified label. Axelson and colleagues
Pregnancy and the postpartum period
Pregnancy planning, pregnancy, and the postpartum period require specialized risk-benefit assessment for psychiatric symptoms, sleep disruption, relapse prevention, and medication exposure. Valproate presents particular reproductive hazards; lithium and other medications also require individualized review. People who are pregnant, may become pregnant, or are planning pregnancy should seek a coordinated discussion with their mental-health prescriber and reproductive care team before changing treatment. NICE bipolar guidance and perinatal referral
Older adults
New symptoms of activation later in life require careful assessment of medication effects, neurological and medical causes, sleep disturbance, and cognitive change. Medication interactions and physical-health monitoring can be particularly important. Treatment decisions should account for the person's overall health and past mood history, rather than applying findings from younger adult research without modification. NICE older adult guidance
Living with diagnostic uncertainty
An other-specified diagnosis can feel unsettling because its name seems incomplete. In clinical practice it often reflects precision: the clinician has identified a meaningful symptom pattern and has also acknowledged which formal criterion is not established. The most helpful next step is to understand the recorded reason and the plan for evaluating new information. It is reasonable to request an explanation in ordinary language and a copy of the care plan. NICE shared assessment and care planning
A symptom timeline can be useful when it records dates, sleep quantity and perceived sleep need, mood, energy, medication changes, substance use, stressors, observed behaviors, and effects on daily life. A simple journal is more informative than a constantly changing collection of online labels. Records can improve discussions with professionals but cannot determine which DSM criteria have been met. VA/DoD care resources
People can also identify stable supports and habits that make monitoring more manageable: regular opportunities for sleep, a plan for contacting clinicians when clear changes emerge, agreed boundaries around major decisions during periods of unusual activation, and attention to co-occurring depression or anxiety. These measures are individualized components of care; they are not proof that a specific lifestyle factor caused the symptoms. NICE relapse-prevention recommendations
Relatives and partners can be helpful by describing concrete changes rather than assigning a diagnosis: “you slept two hours and were still very energetic for several days,” for example, conveys more clinical information than “you were bipolar this week.” Supporters should respect confidentiality and autonomy while responding to urgent safety needs when they arise. NIMH symptoms and assessment
Common misunderstandings
“Other specified means the symptoms do not count.”
The category exists precisely because clinically significant bipolar-like presentations may require treatment and follow-up even when one or more categorical criteria are unmet. A professional explanation of the exact unmet criterion is central to its correct use. APA clinical classification note
“It means I will definitely have bipolar I or bipolar II later.”
Longitudinal studies identify progression in some subthreshold groups but also demonstrate variation in course. Neither a cohort proportion nor a research label can predict one individual's future diagnosis. Clinical follow-up is more informative than treating a population average as destiny. Axelson and colleagues
“Brief hypomania is the same thing as mania.”
Hypomania and mania have different episode criteria and clinical consequences. Severe impairment, need for hospitalization, and psychosis are especially important distinctions. A short but extremely severe activated state warrants urgent assessment rather than casual labeling as a minor hypomanic episode. NIMH explanation of manic and hypomanic episodes
“Any mood-tracking app can confirm the diagnosis.”
An app may record valuable observations, but it does not independently establish sustained mood episodes, functional change, exclusions, or longitudinal diagnostic criteria. Online quizzes and self-reported screening measures can support a conversation with a professional and should not replace that evaluation. NICE assessment guidance
Questions to ask a clinician
A useful appointment can focus on practical specificity: Which DSM-5-TR other-specified pattern best describes my history? Which exact requirement for another bipolar diagnosis is not met? Are the activated periods distinct from depression, sleep loss, medications, or substance effects? Have any manic or psychotic symptoms appeared? What additional records or collateral observations would improve diagnostic confidence? APA classification note
Further questions concern care: Which symptoms should we treat now? What is the evidence for the proposed treatment in my specific presentation rather than bipolar I or II alone? What physical-health monitoring is necessary? What signs mean I should contact the team before the next appointment? When will we review the diagnosis? These questions help translate an uncertain label into a concrete treatment and monitoring plan. VA/DoD recommendations
Frequently asked questions
Is other specified bipolar and related disorder an official DSM-5-TR diagnosis?
Yes. It is a recognized DSM-5-TR diagnostic category. The clinician should identify the precise reason the person's clinically significant bipolar-related presentation fails to meet full criteria for another specific bipolar or related diagnosis. American Psychiatric Association
Is other specified bipolar disorder the same as bipolar NOS?
They are related historically but are not exact interchangeable codes or descriptions. The older bipolar disorder not otherwise specified terminology was used within an earlier diagnostic framework. DSM-5 and DSM-5-TR distinguish “other specified” presentations from “unspecified” ones according to whether the reason for unmet criteria is stated. Research based on an older NOS population should be interpreted in that historical context. APA DSM-5-TR changes
Can someone have other specified bipolar disorder without depression?
Yes. The DSM-5-TR examples include a hypomanic episode without a prior major depressive episode, subject to full clinical evaluation and diagnostic exclusions. Other recognized examples do involve major depressive episodes, so a clinician needs to name which pattern applies. APA explanation
Can short episodes lasting two or three days matter?
Yes, when the periods represent genuine, characteristic changes in mood and energy with clinical significance. Two- or three-day hypomanic-like episodes are among the specified examples when paired with the appropriate major depressive history. Duration alone never establishes the diagnosis; episode quality, symptoms, impairment or distress, and alternative causes must also be assessed. Miller and colleagues
Does this diagnosis require medication?
No medication follows automatically from the label. Clinicians choose treatment using the observed syndrome, severity, current phase, previous history, likely benefit, adverse effects, and diagnostic uncertainty. Most medication evidence comes from more clearly defined bipolar I and II populations, and its transfer to other-specified conditions needs explicit clinical reasoning. CANMAT/ISBD 2023
Can the diagnosis change after later episodes?
Yes. A subsequent well-documented episode, an expanded medical history, or a different explanation for earlier symptoms can change diagnostic formulation. Longitudinal follow-up is part of good psychiatric care, particularly for presentations whose episode duration or symptom count lies below a formal threshold. NIMH clinical diagnosis guidance
Is other specified bipolar disorder necessarily less serious?
No. The category identifies a particular diagnostic pattern, not a universal position on a severity ladder. A person may experience distressing depressive symptoms, functional disruption, unsafe activated behavior, or substantial uncertainty despite not fulfilling one criterion for bipolar I or II. Severity and safety must be assessed individually. NICE risk and functioning assessment
What is the difference from bipolar spectrum?
“Bipolar spectrum” is a broader clinical and research expression whose definitions vary. Other specified bipolar and related disorder is a formal DSM diagnostic category with an explicit reason for unmet criteria. The terms sometimes overlap conceptually, but a broad spectrum description is not itself a substitute for recording a DSM diagnosis. Oliva and colleagues
Related Articles
References
American Psychiatric Association. (2022). Other specified bipolar and related disorder: DSM-5-TR changes and rationale. Official APA DSM-5-TR fact sheet.
American Psychiatric Association. (2025). DSM-5-TR Update, September 2025, II.A Other Specified Bipolar and Related Disorder. Official APA update, p. 6.
Axelson, D. A., et al. (2011). Course of subthreshold bipolar disorder in youth: Diagnostic progression from bipolar disorder not otherwise specified. Journal of the American Academy of Child & Adolescent Psychiatry, 50(10), 1001–1016.e3. https://doi.org/10.1016/j.jaac.2011.07.005
Keramatian, K., Chithra, N. K., & Yatham, L. N. (2023). The CANMAT and ISBD guidelines for the treatment of bipolar disorder: Summary and a 2023 update of evidence. Focus, 21(4), 344–353. https://doi.org/10.1176/appi.focus.20230009
Merikangas, K. R., et al. (2011). Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative. Archives of General Psychiatry, 68(3), 241–251. https://doi.org/10.1001/archgenpsychiatry.2011.12
Miller, S., Dennehy, E. B., & Suppes, T. (2016). The prevalence and diagnostic validity of short-duration hypomanic episodes and major depressive episodes. Current Psychiatry Reports, 18, Article 27. https://doi.org/10.1007/s11920-016-0669-2
National Institute for Health and Care Excellence. (2014; updated guidance). Bipolar disorder: Assessment and management (CG185). Official NICE recommendations
National Institute of Mental Health. (n.d.). Bipolar disorder. NIMH public clinical overview
Oliva, V., Fico, G., De Prisco, M., Gonda, X., Rosa, A. R., & Vieta, E. (2025). Bipolar disorders: An update on critical aspects. The Lancet Regional Health – Europe, 48, 101135. https://doi.org/10.1016/j.lanepe.2024.101135
Singh, B., et al. (2025). Bipolar disorder. The Lancet, 406(10506), 963–978. https://doi.org/10.1016/S0140-6736(25)01140-7
U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for management of bipolar disorder. Official guideline and supporting tools